Lv1
60 积分 2024-10-03 加入
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
2天前
已完结
Unconventional PROTACs for cancer therapy
2天前
已完结
Acquisition of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-Tagged Combinatorial Synthesis and Screening Strategy
9天前
已完结
Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader
11天前
已完结
Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy
12天前
已关闭
Targeting Protein Tyrosine Phosphatase Nonreceptor Type 2 with a Novel Inhibitor for the Treatment of Melanoma
12天前
已完结
Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site
13天前
已完结
Structure‐Based Optimization of Protein Tyrosine Phosphatase‐1 B Inhibitors: Capturing Interactions with Arginine 24
13天前
已完结
A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
17天前
已完结
Therapeutic potential of targeting LSD1/ KDM1A in cancers
18天前
已完结
皖公网安备34019202002308
